Iluvien (fluocinolone acetonide intravitreal implant) 0.18 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iluvien (fluocinolone acetonide intravitreal implant) 0.18 mg, covering 2024-08-06 to 2024-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis [Phase 4]